Dairo earned his Master's degree in cell and molecular biology from Western Illinois University, USA. First, he studied the antiproliferative and cytotoxic effects of Morchella esculenta (morel mushroom) extracts on pancreatic cancer cell lines (MIA PaCa-2) in the lab of Dr. Mette Soendergaard. Also, in the lab of Dr. John Determan, he used a computational approach, including molecular docking, molecular dynamics simulation, and density functional theory, to demonstrate the interaction of Morel mushroom compounds with RNA-Binding protein La implicated in drug resistant ovarian cancer. He also used a computational approach to give insight into the pharmacokinetic and physicochemical properties of Viscum album (mistletoe) bioactive compounds as inhibitors of p63 for the treatment of pancreatic ductal adenocarcinoma.
Dairo joined Dr. Timothy Hla's lab in June 2023 to undergo sophisticated training and study sphingolipids and their metabolism in physiology and disease.
Publications Highlights:
Dairo, G. S. (2023). Compounds from Morchella esculenta as Potential Inhibitors of RNA-Binding Protein La in Ovarian Cancer: A Molecular Modeling and Quantum Mechanics Approach (Doctoral dissertation, Western Illinois University).
Dairo, G., Ilesanmi, A., Balogun, T., Ward, M., Soendergaard, M., & Determan, J. (2023). Computational evaluation of bioactive compounds from Viscum album (mistletoe) as inhibitors of p63 for pancreatic cancer treatment. Journal of Biomolecular Structure and Dynamics, 1-15.
Balogun, T. A., Chukwudozie, O. S., Dairo, G., Junaid, I. O., Sunday, O. A., Ige, O. M., ... & Sabatier, J. M. (2022). Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. Frontiers in Chemistry, 10, 964446.
Email: Gbenga.Dairo@childrens.harvard.edu